Michael O. Idowu, MB is an expert in the field of Pathology. Michael O. Idowu, MB is a published doctor as well. He has 33 publications published. The latest was: A Phase II Study of 3'-Deoxy-3'-18F-Fluorothymidine PET in the Assessment of Early Response of Breast Cancer to Neoadjuvant Chemotherapy: Results from ACRIN 6688. He accepts Medicare payments and is listed with Medicare.gov.
 Virginia Commonwealth University Health System
 Memorial Sloan-Kettering Cancer Center
 University of Ibadan| National Provider Identifier [NPI] | 1962413310 | 
| Last Name Of The Provider | IDOWU | 
| First Name Of The Provider | MICHAEL | 
| View All | 
             
           | 
          Dr. Sarah E. Gibson, MD
               This Doctor is OpenDoctor Recommended.
           | 
        
             
           | 
          Dr. Sukru S. Demirci, MD
               This Doctor is OpenDoctor Recommended.
           | 
        
             
           | 
          Dr. Adele O. Kraft, MD
               This Doctor is OpenDoctor Recommended.
           | 
        
             
           | 
          Dr. Enrique Gerszten, MD
               This Doctor is OpenDoctor Recommended.
               This doctor has more publications
           | 
        
             
           | 
          Dr. Yasmin I. Lutterbie, MD
               This Doctor is OpenDoctor Recommended.
           | 
        
             
           | 
          Dr. David M. Capuzzi, MD
               This Doctor is OpenDoctor Recommended.
           | 
        
             
           | 
          Dr. Andrea G. Jelinek, DO | 
             
           | 
          Dr. Austin B. Wiles, MD
               This Doctor is OpenDoctor Recommended.
           | 
        
             
           | 
          Dipti A. Surve, MB BS
               This Doctor is OpenDoctor Recommended.
           |